These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2935084)

  • 21. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recent advances in the treatment of advanced breast cancer: therapeutic modalities at the National Cancer Center Hospital].
    Adachi I; Suzuki M; Tsuchihashi T; Yamaguchi K; Abe K
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):793-800. PubMed ID: 3566292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular predictive factors for local recurrence and distant metastasis of breast cancer after lumpectomy with postoperative radiation therapy.
    Amornmarn R; Bui MM; Prempree TB; Masood S
    Ann Clin Lab Sci; 2000 Jan; 30(1):33-40. PubMed ID: 10678581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
    Giralt E; Jouve M; Palangie T; Bretaudeau B; Asselain B; Magdelenat H; Merle S; Zajdela A; Pouillart P
    Bull Cancer; 1984; 71(1):22-9. PubMed ID: 6324934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
    Garg AK; Strom EA; McNeese MD; Buzdar AU; Hortobagyi GN; Kuerer HM; Perkins GH; Singletary SE; Hunt KK; Sahin A; Schechter N; Valero V; Tucker SL; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):138-45. PubMed ID: 15093909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical margin and breast recurrence after breast-conserving therapy.
    Horiguchi J; Iino Y; Takei H; Maemura M; Yokoe T; Niibe H; Yamakawa M; Nakajima T; Oyama T; Morishita Y
    Oncol Rep; 1999; 6(1):135-8. PubMed ID: 9864416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up.
    Hubay CA; Gordon NH; Crowe JP; Guyton SP; Pearson OH; Marshall JS; Mansour EG; Hermann RE; Jones JC; Flynn WJ
    Surgery; 1984 Jul; 96(1):61-72. PubMed ID: 6740497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.
    Mathew J; Agrawal A; Asgeirsson KS; Buhari SA; Jackson LR; Cheung KL; Robertson JF
    Breast Cancer Res Treat; 2009 Jan; 113(2):403-7. PubMed ID: 18311583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A randomized clinical trial of adjuvant endocrine therapy after breast conserving surgery for early breast cancer. Cooperative Study Group for Breast Conserving Therapy].
    Nakamura Y; Tominaga T; Nomura Y; Koyama H; Miura S; Morimoto T
    Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():217-25. PubMed ID: 8037485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinicopathological features of recurrent breast cancer].
    Izuo M
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):412-20. PubMed ID: 4004278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
    Davidson NE; O'Neill AM; Vukov AM; Osborne CK; Martino S; White DR; Abeloff MD
    J Clin Oncol; 2005 Sep; 23(25):5973-82. PubMed ID: 16087950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of subcutaneous mastectomy with radical mastectomy.
    Horiguchi J; Iino JHY ; Takei H; Koibuchi Y; Iijima K; Ikeda F; Ochiai R; Uchida K; Yoshida M; Yokoe T; Morishita Y
    Anticancer Res; 2001; 21(4B):2963-7. PubMed ID: 11712794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment guideline for advanced or recurrent breast cancer].
    Watanabe T; Katsumata N; Saijo N
    Nihon Rinsho; 2000 Apr; 58 Suppl():237-45. PubMed ID: 11026001
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mammary gland carcinoma treated by large-dose medroxyprogesterone acetate of which pulmonary metastases disappeared and a selection of hormone, chemoimmunological treatment].
    Matsumoto S; Kutsuna T; Tann M; Mizuno Y; Shinohara M; Kimura T; Banno T; Yoshizaki S
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2457-9. PubMed ID: 2526619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer.
    Hartmann LC; Loprinzi CL
    Cancer Chemother Biol Response Modif; 1990; 11():510-30. PubMed ID: 2223405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.
    Noguchi S; Yamamoto H; Inaji H; Imaoka S; Koyama H
    Jpn J Cancer Res; 1989 Mar; 80(3):244-8. PubMed ID: 2524460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery, kinetics and biological considerations in planning adjuvant therapy protocols.
    Forbes JF
    Prog Clin Biol Res; 1990; 354A():133-46. PubMed ID: 2247485
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnosis and therapy of advanced breast carcinoma: summary of the NICE guidelines].
    Murray N; Winstanley J; Bennett A; Francis K
    Praxis (Bern 1994); 2009 Aug; 98(17):961-4. PubMed ID: 19711289
    [No Abstract]   [Full Text] [Related]  

  • 39. Medroxyprogesterone acetate (MAP) and tamoxifen (TMX) plasma levels after simultaneous treatment with 'low' TMX and 'high' MAP doses.
    Camaggi CM; Strocchi E; Canova N; Costanti B; Pannuti F
    Cancer Chemother Pharmacol; 1985; 14(3):229-31. PubMed ID: 3158448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
    Kauppila A
    Acta Obstet Gynecol Scand; 1984; 63(5):441-50. PubMed ID: 6238499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.